Simplex Trading, LLC Karyopharm Therapeutics Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$0.72 - $1.66 $25,188 - $58,073	34,984 Added 166.58%	55,985 $84,000
Q4 2023 Feb 02, 2024	SELL	$0.68 - $1.31 $343 - $661	-505 Reduced 2.35%	21,001 $18,000
Q3 2023 Nov 01, 2023	BUY	$1.14 - $1.81 $24,516 - $38,925	21,506 New	21,506 $28,000
Q4 2022 Feb 02, 2023	BUY	$2.48 - $5.93 $28,745 - $68,734	11,591 Added 199.36%	17,405 $59,000
Q3 2022 Nov 04, 2022	SELL	$4.08 - $5.82 $4,312 - $6,151	-1,057 Reduced 15.38%	5,814 $31,000
Q2 2022 Aug 03, 2022	BUY	$4.15 - $8.37 $28,514 - $57,510	6,871 New	6,871 $30,000
Q1 2022 May 02, 2022	SELL	$5.91 - $14.38 $347,112 - $844,580	-58,733 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$5.21 - $8.61 $305,998 - $505,691	58,733 New	58,733 $377,000
Q3 2021 Oct 28, 2021	SELL	$4.45 - $10.63 $1,263 - $3,018	-284 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$8.11 - $11.11 $22,918 - $31,396	-2,826 Reduced 90.87%	284 $2,000
Q1 2021 Apr 26, 2021	SELL	$9.85 - $17.69 $81,705 - $146,738	-8,295 Reduced 72.73%	3,110 $0
Q4 2020 Feb 02, 2021	BUY	$14.15 - $17.19 $14,220 - $17,275	1,005 Added 9.66%	11,405 $176,000
Q3 2020 Oct 14, 2020	SELL	$14.14 - $19.71 $131,346 - $183,086	-9,289 Reduced 47.18%	10,400 $151,000
Q2 2020 Jul 13, 2020	BUY	$16.6 - $25.25 $326,837 - $497,147	19,689 New	19,689 $372,000
Q1 2020 Apr 29, 2020	SELL	$14.38 - $27.72 $374,153 - $721,246	-26,019 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$9.23 - $19.67 $227,501 - $484,826	24,648 Added 1797.81%	26,019 $498,000
Q3 2019 Oct 15, 2019	SELL	$5.66 - $11.85 $264,525 - $553,821	-46,736 Reduced 97.15%	1,371 $13,000
Q2 2019 Jul 26, 2019	BUY	$4.32 - $6.43 $156,047 - $232,264	36,122 Added 301.39%	48,107 $288,000
Q1 2019 Apr 18, 2019	SELL	$4.12 - $10.25 $25,103 - $62,453	-6,093 Reduced 33.7%	11,985 $0
Q4 2018 Jan 16, 2019	BUY	$8.2 - $16.95 $136,907 - $282,997	16,696 Added 1208.1%	18,078 $169,000
Q3 2018 Oct 23, 2018	BUY	$17.03 - $21.18 $23,535 - $29,270	1,382 New	1,382 $23,000
Q2 2018 Jul 30, 2018	SELL	$12.0 - $19.88 $261,696 - $433,543	-21,808 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$9.92 - $17.25 $150,407 - $261,544	15,162 Added 228.14%	21,808 $292,000
Q4 2017 Jan 10, 2018	SELL	$9.15 - $11.99 $113,075 - $148,172	-12,358 Reduced 65.03%	6,646 $63,000
Q3 2017 Oct 25, 2017	BUY	$8.15 - $11.16 $154,882 - $212,084	19,004	19,004 $208,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account